LM N°2/ 2024. ACT 3. THE SAGA OF INDUSTRIAL DEVELOPMENT. FROM BIOMATRIX TO VIVACY TO Q-MED...
SI LA SAGA DE L’AH M’ÉTAIT CONTÉE… ACTE 3. LA SAGA DU DÉVELOPPEMENT INDUSTRIEL.DE BIOMATRIX À Q-MED EN PASSANT PAR VIVACY… Cette saga est racontée dans tous ses détails à partir du travail de Börje Svensson : «The magic molecule – that has improved the lives of millions.» https://books.google.fr/books/about/The_Magic_Molecule_ that_Has_Improved_the.html?id=fmETDAEACAAJ&redir_esc=y “My book, «The Magic Molecule […]
LM N°2/ 2024. ACT 4. THE SAGA OF WALDEMAR KITA: the founder of VIVACY. "Efficient research and quality products and service are the keys to success".
Si la saga de l’AH m’était contée… ACTE 4. LA SAGA DE WALDEMAR KITA : le fondateur de VIVACY. De la fabrication des lentilles intra-oculaires avec la création de la Société CORNEAL en 1987, aux applications de l’acide hyaluronique à base de crêtes de coqs utilisées en chirurgie de la cataracte et du glaucome, puis […]
LM N°2/ 2024. What is the state of hyaluronic acid R&D, today and tomorrow? Michel CHERON PDt and CEO of the VIVACY Group Interview by Pr AC BENHAMOU
Hyaluronic acid is at the heart of your industrial research and the development of medical applications for hyaluronic acid. Can you tell us about Vivacy's current development in this sector?
LM N°2/ 2024. STATE OF RESEARCH IN 2024. ALTERATIONS IN MUCOSAL TRANSUDATION IN VULVOVAGINAL ATROPHY: WHAT MECHANISMS ARE INVOLVED? THE ROLE OF HYALURONIC ACID IN INFLUENCING VAGINAL LUBRICATION. Denis COUCHOUREL, PhD Scientific and Medical Director, Laboratoires VIVACY
The state of the art in 2024 on HA research ALTERATIONS OF MUQUEOUS TRANSSUDATION IN VULVO- VAGINAL ATROPHIES: WHAT MECHANISMS ARE INVOLVED? THE ROLE OF HYALURONIC ACID IN INFLUENCING VAGINAL LUBRICATION. Denis COUCHOUREL, PhD Scientific and Medical Director, VIVACY Laboratories INTRODUCTION In 2014, the [...]
LM N°2/ 2023. Theme 1: Genitourinary health after breast cancer. Hyaluronic acid: from endogenous molecules to injectable gels. Denis Couchourel, Phd, Vivacy Laboratory
Hyaluronic acid: from the endogenous molecule to injectable gels Denis COUCHOUREL, PhD Scientific and Medical Director, Laboratoires VIVACY Hyaluronic acid is an endogenous molecule essential to extracellular matrices, with remarkable properties that are exploited by the body in very specific compartments (vitreous humor, joint cavity...). It is also a biologically active molecule involved in the [...]
LM N° 3/ 2022. Another look. Hyaluronic acid and tissue regeneration. Denis Couchourel PhD, MBA Scientific & Medical Director Laboratoires Vivacy
Another look Hyaluronic acid and tissue regeneration Denis Couchourel PhD, MBA Scientific & Medical Director Vivacy Laboratories Introduction The first publications describing the clinical results of hyaluronic acid (HA) used as dermal filling material for aesthetic purposes date back to the early 2000s (Duranti F et al, 1998 ; Pollack S, [...]
LM N°1/2020. Video. Vaginal rejuvenation with DESIRIAL PLUS by VIVACY
https://vimeo.com/manage/471463511/general
LM N°1/2020. Subjects still taboo. Video presentation : " Vaginal rejuvenation with DESIRIAL PLUS " . By VIVACY
LM N°1/2020. Vaginal rejuvenation with DESIRIAL PLUS by VIVACY / VIDEO
https://vimeo.com/manage/472281421/general https://vimeo.com/manage/471463511/general https://vimeo.com/manage/471464068/general
